CPhI North America is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


View, browse and sort the ever-growing list of sessions by pass type, track, and format. With this Session Scheduler, you can build your schedule in advance and access it during the show via export or with the Mobile App, once live. Sessions do fill up and seating is first come, first serve, so arrive early to sessions that you would like to attend.

Unlocking the potential of cannabinoid derived drugs

Josh Hoerner, PhD  (Chief Innovation Officer, Managing Director, Purisys Athens)

Jessica Rousset  (Chief Operating Officer, CURE)

Brian Furmanski, Ph.D.  (Senior Director of Clinical Pharmacology and Regulatory Affairs, Nuventra Pharma Sciences)

Scott Watson  (Principal, The C=C Bond Group)

Pass Type: VIP Attendee, Exhibitor, Expo & Conference, Matchmaking - Get your pass now!

Track: Drug Development & Delivery

Vault Recording: TBD

- Current market overview
– GW's epilepsy drug
- Potential for application to other therapy areas
- Synthetic vs natural - Development challenges
- Regulatory perspectives